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The aim of this study was to investigate whether tumour hypoxia and/or vascular hot spots promote the development of
metastatic disease. The D-12 human melanoma xenograft line was used as a tumour model. Hypoxia and vascular hot spots
were detected by immunohistochemistry using pimonidazole as a hypoxia marker and anti-CD31 antibody to visualize
endothelial cells. Vascular hot spots were found to be induced in hypoxic foci, owing to hypoxia-induced up-regulation of
angiogenesis stimulatory factors. This effect was mediated by interleukin 8 and possibly also by vascular endothelial growth
factor. Interleukin 8 positive foci showed a high degree of co-localization with hypoxic foci, as revealed by
immunohistochemistry. The incidence of spontaneous pulmonary metastases was associated with the density of hypoxic
foci, the density of interleukin 8 positive foci and the density of vascular hot spots in the primary tumour. Treatment with
neutralizing antibody against interleukin 8 and/or vascular endothelial growth factor resulted in hypoxia-induced necrosis rather
than hypoxia-induced vascular hot spots and inhibited metastasis. Our study suggests a cause-effect relationship between
hypoxia and metastasis in cancer and hence an elevated probability of metastatic disease in patients having primary tumours
characterized by high densities of hypoxic foci and vascular hot spots.
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Most human tumours develop a pathophysiological microenviron-
ment during growth, characterized by an irregular microvascular
network and regions of chronically and transiently hypoxic cells
(Vaupel et al, 1989). Side by side with the generation of an abnor-
mal microenvironment, tumours gradually acquire aggressive
phenotypic traits with time, a process termed malignant progres-
sion (Nowell, 1986). The ﬁnal stage of the malignant progression
is the development of cell variants showing invasive growth in
surrounding normal tissues and metastatic spread to regional and
distant organ sites. There is signiﬁcant evidence that the microen-
vironment may accelerate the malignant progression of tumours
and promote the development of metastatic disease (Rofstad,
2000). Thus, some tumour cells exposed to hypoxia in vitro show
increased lung colonization efﬁciency after intravenous inoculation
in mice (Young et al, 1988; Rofstad and Danielsen, 1999). More-
over, clinical studies have demonstrated associations between
incidence of metastases and extent of hypoxia in the primary
tumour in soft tissue sarcoma (Brizel et al, 1996) and cervical
carcinoma (Ho ¨ckel et al, 1996; Rofstad et al, 2000). These clinical
studies, however, do not necessarily implicate a cause–effect rela-
tionship between hypoxia and metastasis. An alternative
interpretation is that poor oxygenation is a secondary effect of
tumour aggressiveness, i.e. the most aggressive cell phenotypes
develop the most hypoxic primary tumours. There is also signiﬁ-
cant evidence that tumour hypoxia may be of limited
signiﬁcance in cancer metastasis (Rofstad, 2000). Thus, clinical
studies involving several histological types of cancer have demon-
strated associations between incidence of metastases and
microvessel density in vascular hot spots of the primary tumour
(Weidner, 1995). These studies are apparently inconsistent with
those showing associations between hypoxia and metastasis,
because tumour hypoxia is expected to be partly a result of poor
oxygen supply owing to inadequate neovascularization (Vaupel et
al, 1989). It has been hypothesized, however, that vascular hot
spots may result from hypoxia-induced neovascularization
mediated by angiogenesis stimulatory factors that are being up-
regulated during hypoxia (Rofstad, 2000). The human melanoma
xenograft study reported in the present communication supports
this hypothesis and demonstrates further an association between
spontaneous pulmonary metastasis on the one hand and hypoxia
and vascular hot spots in the primary tumour on the other. The
hypoxia-induced neovascularization was found to be mediated by
interleukin 8 (IL-8), a multifunctional cytokine that shows potent
angiogenic activities in vitro and in vivo (Bar-Eli, 1999), and
possibly by vascular endothelial growth factor (VEGF), a strong
speciﬁc mitogen for endothelial cells that also stimulates endothe-
lial cell migration and reorganization (Ferrara and Davis-Smyth,
1997). The present communication also indicates a cause–effect
relationship between hypoxia and metastasis in cancer, because
the primary tumours in our study were initiated from the same
monolayer cell culture of D-12 melanoma cells.
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sMATERIALS AND METHODS
Cell line
The experiments were performed with the human melanoma cell
line D-12 (Rofstad, 1994). The cells were maintained in monolayer
culture in RPMI-1640 (25 mM HEPES and L-glutamine) supple-
mented with 13% bovine calf serum, 250 mg l
71 penicillin and
50 mg l
71 streptomycin. The cultures were incubated at 378Ci n
a humidiﬁed atmosphere of 5% CO2 in air and subcultured twice
a week. The cell line was veriﬁed to be free from Mycoplasma
contamination.
Hypoxia treatment
Monolayer cell cultures were exposed to hypoxia by using the steel-
chamber method. The steel chambers were ﬂushed with a humidiﬁed,
highly puriﬁed gas mixture consisting of 95% N2 and 5% CO2 at a
ﬂow rate of 5 l min
71. The concentration of O2 in the medium
was 510 p.p.m. after 30 min of ﬂushing. Details of the procedure
have been published elsewhere (Rofstad and Danielsen, 1999).
VEGF and IL-8 expression in vitro
The expression of VEGF and IL-8 in D-12 cells was studied by
Western blotting using standard experimental procedures (Rofstad
and Halsør, 2000). Membranes were incubated with anti-human
VEGF rabbit polyclonal antibody (Santa Cruz Biotechnology, Santa
Cruz, CA, USA) or anti-human IL-8 mouse monoclonal antibody
(R&D Systems, Abingdon, UK). Bound antibody was detected by
a biotin–streptavidine alkaline phosphatase staining procedure.
Recombinant human VEGF or IL-8 was used as positive control.
The speciﬁcity of the antibody–antigen interactions was conﬁrmed
by peptide competition studies and by incubation of membranes in
solutions without primary antibody.
VEGF and IL-8 secretion in vitro
The secretion of VEGF and IL-8 in D-12 cells was studied by
ELISA as described in detail elsewhere (Rofstad and Danielsen,
1999). Medium samples were collected from aerobic cultures in
exponential growth and cultures exposed to hypoxia. Commercial
ELISA kits (Quantikine; R&D Systems, Abingdon, UK) were used
according to the instructions of the manufacturer to measure the
concentrations of VEGF and IL-8 in the medium samples. Rate
of protein secretion (Rsec) was calculated as:
Rsec 
VC
Nit

lnNf=Ni
Nf=Ni ÿ 1
where DC is the increase in protein concentration during the time
interval Dt. Ni and Nf are the initial and ﬁnal cell numbers and V is
the volume of medium. The second factor of the product is based
on the assumption that the cell number increased exponentially
with time during Dt, an assumption that was veriﬁed to be valid
for aerobic cultures. There was no cell proliferation under hypoxic
conditions, i.e. the second factor of the product was approximately
1 for hypoxic cultures.
Mice and tumours
Adult (8–10 weeks of age) female BALB/c-nu/nu mice were used
as host animals for xenografted tumours. The mice were bred at
our institute and maintained under speciﬁc pathogen-free condi-
tions at constant temperature (24–268C) and humidity (30–
50%). Sterilized food and tap water were given ad libitum.
Tumours were initiated from exponentially growing aerobic mono-
layer cell cultures. Approximately 3.5610
5 cells suspended in 10 ml
of Ca
2+ and Mg
2+-free Hanks’ balanced salt solution (HBSS) were
inoculated intradermally into the ﬂanks of mice. The growth and
histological appearance of the tumours have been described else-
where (Rofstad, 1994). Animal experiments were approved by the
Institutional Committee on Research Animal Care and were
performed according to the ethical standards of the UKCCCR
‘Guidelines for the Welfare of Animals in Experimental Neoplasia’.
VEGF and IL-8 expression in vivo
The expression of VEGF and IL-8 in D-12 tumours was studied by
immunohistochemistry using an indirect immunoperoxidase meth-
od (Rofstad and Halsør, 2000). Tumours were cut into 1-mm-thick
slices that were ﬁxed in phosphate-buffered 4% paraformaldehyde
or snap-frozen in liquid nitrogen. Anti-human VEGF rabbit poly-
clonal antibody (Santa Cruz Biotechnology, Santa Cruz, CA,
USA) or anti-human IL-8 rabbit polyclonal antibody (Endogen,
Woburn, MA, USA) was used as primary antibody. Controls
included omission of the primary antibody, incubation with
normal rabbit immunoglobulin or normal rabbit serum and incu-
bation with blocking peptides before staining. The sections were
counterstained with haematoxylin. Quantitative analyses were
based on eight cross-sections of each tumour.
Tumour hypoxia
Pimonidazole {1-[(2-hydroxy-3-piperidinyl)propyl]-2-nitroimida-
zole} was used as a marker of tumour hypoxia. Hypoxic tumour
regions were detected immunohistochemically as reported earlier
by using a peroxidase-based indirect staining method (Rofstad and
Ma ˚seide, 1999). Pimonidazole hydrochloride, kindly supplied by
Professor JA Raleigh, was dissolved into 0.9% NaCl and administered
i.p. to tumour-bearing mice in doses of 30 mg kg
71 body weight.
The tumours were dissected free from the mice 4 h after the pimoni-
dazole administration and 1-mm-thick tumour slices were ﬁxed in
phosphate-buffered 4% paraformaldehyde. Slides with tumour tissue
preparations were incubated with polyclonal rabbit antiserum to
pimonidazole–protein adducts, a kind gift from Professor JA
Raleigh. Visualization of the antibody complex was achieved with
the 3,3-diaminobenzidine chromogen. Haematoxylin was used for
counterstaining. Eight cross-sections of each tumour were subjected
to quantitative analyses. Area fractions showing pimonidazole stain-
ing and area fractions of necrosis were determined by image analysis
as described elsewhere (Rofstad and Ma ˚seide, 1999).
Tumour vascularization
The microvasculature of tumours was detected by immunohisto-
chemistry using an avidin–biotin peroxidase-based staining
method. Histological sections were prepared from 1-mm-thick
tumour slices snap-frozen in liquid nitrogen. Anti-mouse CD31 rat
monoclonal antibody (Research Diagnostics, Flanders, NJ, USA)
was used as primary antibody. The 3,3-diaminobenzidine chromogen
was used to visualize endothelial cells. Controls included omission of
the primary antibody and incubation with blocking peptide before
staining. The preparations were counterstained with haematoxylin.
Quantitative analyses were based on eight cross-sections of each
tumour. Microvessel density was scored by deﬁning single, countable
microvessels as deﬁned by Weidner (1995).
Metastasis assay
Primary tumours were initiated in the left ﬂank of mice from
monolayer cell cultures as described above. The inoculations were
performed 24 h after the mice had been immunosuppressed by
5.0 Gy of whole body irradiation (Rofstad and Halsør, 2000). D-
12 primary tumours suppress the growth of pulmonary microme-
tastases by secreting large quantities of the angiogenesis inhibitor
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sthrombospondin-1 (Rofstad and Graff, 2001). The primary
tumours were removed surgically when the largest diameter had
attained a predetermined size to allow pulmonary micrometastases
to develop into macroscopic metastases. The mice were examined
twice a week for clinical signs of metastases, i.e. listlessness, weight
loss or hunched posture. They were killed by cervical dislocation 3
months after the primary tumour was removed or when moribund.
The lungs were examined for the presence of macroscopic metas-
tases as described elsewhere (Rofstad and Halsør, 2000).
Metastases were always found in moribund mice.
Treatment with neutralizing antibody
The speciﬁc roles of VEGF and IL-8 in tumour metastasis were
investigated by treating host mice with neutralizing antibody. The
antibodies used for treatment were anti-human VEGF mouse
monoclonal antibody (R&D Systems, Abingdon, UK) and anti-
human IL-8 mouse monoclonal antibody (R&D Systems, Abing-
don, UK). Antibody solutions were diluted in PBS and
administered in volumes of 0.25 ml by i.p. injection. The treat-
ments were given during the last 8 days before primary tumour
removal and consisted of daily doses of 25 mg of anti-VEGF anti-
body, 100 mg of anti-IL-8 antibody, or both 25 mg of anti-VEGF
antibody and 100 mg of anti-IL-8 antibody. Antibody treatment
had no effect on tumour blood ﬂow, as determined in separate
experiments by using the
86Rb uptake method.
Statistical analysis
Data are presented as arithmetic mean+s.e.m. Correlations
between two parameters were searched for by linear regression
analysis. Statistical comparisons of data were performed by using
the Student’s t-test (single comparisons) or by one-way ANOVA
(multiple comparisons) under conditions of normality and equal
variance. Under other conditions, comparisons were performed
by non-parametric analysis using the Mann–Whitney rank sum
test (single comparisons) or the Kruskal–Wallis one-way ANOVA
on ranks (multiple comparisons). The Bonferroni’s method (para-
metric tests) or the Dunnett’s method (non-parametric tests) was
used to identify data sets that differed from control data. Probabil-
ity values of P50.05 were considered signiﬁcant. All P-values were
determined from two-sided tests. The statistical analysis was
performed by using the SigmaStat statistical software (Jandel Scien-
tiﬁc GmbH, Erkrath, Germany).
RESULTS
Expression of VEGF and IL-8 in vitro
D-12 cells showed moderate secretion of VEGF and high secretion
of IL-8 in vitro, as revealed by ELISA analysis. The rate of VEGF
secretion was higher under hypoxic conditions (Rsec=121+21 pg/
(h×10
6 cells); n=5) than under aerobic conditions (Rsec=18+1 pg/
(h×10
6 cells); n=5) by a factor of approximately 7 (P=0.0012). Simi-
larly, the rate of IL-8 secretion was higher under hypoxic
conditions (Rsec=1128+184 pg/(h×10
6 cells); n=5) than under
aerobic conditions (Rsec=291+86 pg/(h×10
6 cells); n=5) by a factor
of approximately 4 (P=0.0033). Western blot analysis revealed that
D-12 cells showed signiﬁcant expression of VEGF and IL-8 in vitro
and that the expression of both angiogenesis factors was up-regu-
lated under hypoxic conditions (data not shown), consistent with
the ELISA data.
Hypoxia, vascularization and expression of VEGF and IL-8
in vivo
Hypoxic pattern, vascular organization and the expression of VEGF
and IL-8 in D-12 tumours were studied by immunohistochemistry,
using tumours with diameters of approximately 10 mm. The
tumours showed highly heterogeneous staining for pimonidazole,
consistent with staining of chronically hypoxic cells without stain-
ing of normoxic or acutely hypoxic cells, as described earlier
(Rofstad and Ma ˚seide, 1999). High-power examination of stained
regions showed the staining to be discrete and mainly intracellular.
Staining was seen primarily in the cytoplasm, but prevalent intra-
nuclear staining also occurred frequently. The boundary line
between stained and unstained cells was remarkably sharp, i.e.
the cells showed either intense brown staining or no staining. Thus,
hypoxic cells could easily be distinguished from normoxic cells.
Necrotic regions were always encompassed by a rim of hypoxic
cells, 2–4 cell layers thick, as illustrated elsewhere (Rofstad and
Ma ˚seide, 1999). Moreover, foci of hypoxic cells scattered through-
out the tissue were seen in tumour regions without necrosis
(Figure 1A). The shape and size of the hypoxic foci differed
substantially. Hypoxic foci without necrosis had a longest diameter
of up to 800 mm.
The tumours showed highly heterogeneous staining also for
CD31, consistent with staining of endothelial cells. Isolated micro-
vessels as well as clusters of microvessels, i.e. vascular hot spots,
were seen in tumour regions without necrosis. High-power inspec-
tion of vascular hot spots revealed functional microvessels, i.e.
lumens with erythrocytes encircled by endothelial cells, and indivi-
50mm
25mm
Figure 1 Immunohistochemical preparations of a D-12 tumour. An
avidin-biotin peroxidase-based method was used for staining. Haematoxy-
lin was used for counterstaining. Hypoxic focus visualized by anti-pimonida-
zole antibody staining (A) and section of a vascular hot spot visualized by
anti-CD31 antibody staining (B).
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(Figure 1B). CD31-positive mitotic ﬁgures were seen in some
vascular hot spots. The vascular hot spots differed substantially
in shape and size, showed a longest diameter of up to 800 mm,
and were seen in non-necrotic tissue in both central and peripheral
tumour regions. The microvessel density was 5–10-fold higher
within vascular hot spots than elsewhere in non-necrotic tissue.
Moreover, the tumours showed signiﬁcant staining for both
VEGF and IL-8. The VEGF expression was relatively homogeneous
within tumours, but was slightly up-regulated nearby some necrotic
regions, as illustrated previously (Danielsen and Rofstad, 2000).
The VEGF staining appeared to be localized in the cytoplasm of
the cells. Very few negative cells were observed. The IL-8 expres-
sion, on the other hand, was highly heterogeneous. The IL-8
staining was primarily intracellular and the staining pattern was
similar to that for pimonidazole. Examination of adjacent sections
revealed a high degree of co-localization of IL-8 and pimonidazole
staining (Figure 2). Thus, necrotic regions were always surrounded
by a rim of IL-8 positive cells. These rims were usually slightly
broader than the corresponding hypoxic rims. Moreover, foci of
IL-8 positive cells were seen in tumour regions without necrosis.
When IL-8 positive foci were seen, hypoxic foci were always seen
in the same positions in the adjacent section. The degree of co-
localization the reversed way differed among individual tumours.
When hypoxic foci were seen, IL-8 positive foci were seen in the
same positions in the adjacent section in 84–97% of the cases.
The IL-8 positive foci were generally slightly larger than the
hypoxic foci (Figure 2), and the boundary line between stained
and unstained cells was not so sharp as for pimonidazole staining.
There was no signiﬁcant co-localization of IL-8 positive foci and
vascular hot spots.
Spontaneous metastasis
The frequency of metastatic dissemination as well as the densities
of hypoxic foci, IL-8 positive foci and vascular hot spots in the
primary tumour were determined as a function of time after
tumour initiation to investigate whether vascular hot spots devel-
oped from hypoxic foci and whether the development of hypoxic
foci/vascular hot spots preceded metastatic dissemination. Ten
mice with small D-12 tumours were included in the ﬁrst experi-
ment. The primary tumours were removed when the wet weights
were within the range of 10–50 mg and subjected to histological
examinations. Only vascular hot spots with a longest diameter
within the range of 400–800 mm were included in the measure-
ments to ensure correct hot spot identiﬁcation. The
measurements of the density of hypoxic foci were for the sake of
comparison based on hypoxic foci with a longest diameter within
the same range. As IL-8 positive foci in general were larger than
the corresponding hypoxic foci, the density of IL-8 positive foci
was determined by scoring foci with a longest diameter of up to
1200 mm. The densities of hypoxic foci and vascular hot spots
are plotted vs tumour wet weight in Figure 3. Hypoxic foci were
only just seen in the 10-mg tumour and then the density increased
linearly with the wet weight. Vascular hot spots could not be
detected in tumours with wet weights below 25 mg. For larger
tumours, the density of vascular hot spots increased linearly with
the wet weight with a slope similar to that for the density of
hypoxic foci. The delay in the development of vascular hot spots
relative to the development of hypoxic foci corresponded to a
growth period of 3–4 days. There was an even higher degree of
co-localization of IL-8 and pimonidazole staining in these small
tumours than in the larger tumours described above; the density
of IL-8 positive foci increased with the tumour wet weight in the
same way as the density of hypoxic foci (data not shown). These
small tumours showed relatively homogeneous expression of
VEGF, similar to the larger tumours described above. None of
the 10 host mice developed pulmonary metastases during the 3-
month follow-up period, suggesting that the development of
hypoxic foci/vascular hot spots precedes metastatic dissemination
in D-12 tumours. This was investigated further in a second experi-
ment involving four groups of 10 mice each. The primary tumours
were removed when the wet weights had attained approximately
45 mg (group 1), approximately 60 mg (group 2), approximately
75 mg (group 3) or approximately 90 mg (group 4). Pulmonary
metastases developed in 0 of 10 mice (group 1), 2 of 10 mice
(groups 2 and 3) and 3 of 10 mice (group 4). A plot of the mean
number of metastases per mouse vs mean tumour wet weight for
the four groups is included in Figure 3. These metastasis data
together with the hypoxic foci/vascular hot spots data from the ﬁrst
experiment give strong evidence that metastatic dissemination is
preceded by the development of hypoxic foci/vascular hot spots
in D-12 tumours. Moreover, the primary tumours of group 1 were
subjected to histological examinations. The densities of hypoxic
foci and vascular hot spots (No. mm
72) were determined to be
0.062+0.003 and 0.039+0.002, respectively, consistent with the
hypoxic foci/vascular hot spots data in Figure 3.
A third experiment involving 40 mice was performed to inves-
tigate whether tumour hypoxia, IL-8 expression and/or tumour
neovascularization were associated with spontaneous pulmonary
250mm
250mm
Figure 2 Immunohistochemical preparations of adjacent sections of a
D-12 tumour. An avidin-biotin peroxidase-based method was used for
staining. Haematoxylin was used for counterstaining. IL-8 positive foci
visualized by anti-IL-8 antibody staining (A) and hypoxic foci visualized by
anti-pimonidazole antibody staining (B).
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when the largest diameter had attained approximately 10 mm
and the following parameters were determined and related to
the metastatic status of the hosts: hypoxic fraction, density of
hypoxic foci, normoxic fraction, necrotic fraction, IL-8 positive
fraction, density of IL-8 positive foci, hot spot microvessel
density and density of vascular hot spots. Hypoxic foci, IL-8
positive foci and vascular hot spots were deﬁned as described
above. Nineteen mice developed metastases whereas 21 mice
did not. The primary tumours that gave rise to metastases
showed an approximate 1.5-fold higher density of hypoxic foci
than those that did not give rise to metastases (Figure 4A;
P=0.0021). Similarly, the hypoxic fraction (HF), calculated from
the total area of tissue that stained positive for pimonidazole
(including hypoxic tissue adjacent to necrosis and hypoxic foci
of all sizes) and the total tissue area, was higher in the primary
tumours that developed metastases (HF=14+1%) than in those
that did not develop metastases (HF=11+1%) by a factor of
approximately 1.3 (P=0.041). Neither the normoxic fraction
(NOF) nor the necrotic fraction (NF) differed signiﬁcantly
between metastatic (NOF=63+4%; NF=23+3%) and non-meta-
static (NOF=64+5%; NF=25+4%) primary tumours (P40.05
for both NOF and NF). Moreover, the primary tumours that
metastasized showed an approximate 1.5-fold higher density of
IL-8 positive foci than those that did not metastasize (Figure
4B; P=0.0015). Also the IL-8 positive fraction (IPF), calculated
from the total area of tissue that stained positive for IL-8
(including IL-8 positive tissue adjacent to necrosis and IL-8 posi-
tive foci of all sizes) and the total tissue area, was higher in the
primary tumours that formed metastases (IPF=26+2%) than in
those that did not form metastases (IPF=17+2%) by a factor
of approximately 1.5 (P=0.0030). Finally, the metastatic primary
tumours showed an approximate 1.6-fold higher density of
vascular hot spots than those that did not metastasize (Figure
4C; P=0.0010). The hot spot microvessel density (MVD
(No. mm
72)), on the other hand, did not differ signiﬁcantly
between metastatic (MVD=118+12) and non-metastatic
(MVD=123+11) primary tumours (P40.05). It should be
noticed that although the density of hypoxic foci, IL-8 positive
foci and vascular hot spots differed signiﬁcantly between meta-
static and non-metastatic primary tumours, a substantial
fraction of the non-metastatic tumours showed density values
for hypoxic foci, IL-8 positive foci and vascular hot spots within
the same ranges as those for the metastatic tumours (Figure 4).
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density of hypoxic foci in these primary tumours. Different corre-
lations were found for tumours with low necrotic fractions, i.e.
necrotic fractions below 25% (Figure 5A; R
2=0.80, P50.00001),
and tumours with high necrotic fractions, i.e. necrotic fractions
within the range of 25–50% (Figure 5B; R
2=0.72, P50.00001).
The slope of the regression curve in Figure 5A was not signiﬁcantly
different from unity (P40.05), but was signiﬁcantly higher than
that of the regression curve in Figure 5B (P=0.045).
Treatment with neutralizing antibody
The involvement of VEGF and IL-8 in spontaneous pulmonary
metastasis in D-12 melanoma was investigated by treating host
mice with neutralizing antibody against VEGF, IL-8, or both VEGF
and IL-8 (Figure 6A). Ten of 20 untreated control mice developed
metastases. The incidence of metastases was reduced after anti-
VEGF treatment (P=0.022), anti-IL-8 treatment (P=0.048), and
combined anti-VEGF and anti-IL-8 treatment (P=0.0025). More-
over, the incidence of metastases was lower after combined anti-
VEGF and anti-IL-8 treatment than after anti-VEGF treatment
alone (P=0.048) or anti-IL-8 treatment alone (P=0.022).
The density of hypoxic foci, the density of vascular hot spots
and necrotic fraction were scored in these primary tumours to
investigate whether hypoxic foci and vascular hot spots were
involved in the development of pulmonary metastases in D-12
melanoma (Figure 6B). The control group showed densities of
hypoxic foci and vascular hot spots that were not signiﬁcantly
different (P40.05). The density of hypoxic foci was not inﬂuenced
signiﬁcantly by anti-VEGF treatment (P40.05), anti-IL-8 treat-
ment (P40.05), or combined anti-VEGF and anti-IL-8 treatment
(P40.05). The density of vascular hot spots, on the other hand,
was reduced after anti-VEGF treatment (P=0.0028), anti-IL-8 treat-
ment (P=0.012), and combined anti-VEGF and anti-IL-8 treatment
(P50.00001). Moreover, the density of vascular hot spots was
lower after combined anti-VEGF and anti-IL-8 treatment than after
anti-VEGF treatment alone (P=0.0058) or anti-IL-8 treatment
alone (P=0.0013). The control tumours showed a necrotic fraction
(NF)o f2 2 +3%. The necrotic fraction was increased after anti-
VEGF treatment (NF=38+3%; P=0.0060), anti-IL-8 treatment
(NF=35+4%; P=0.034), and combined anti-VEGF and anti-IL-8
treatment (NF=43+4%; P=0.00022).
DISCUSSION
The incidence of spontaneous pulmonary metastases was associated
with the extent of hypoxia in the primary tumour in D-12 melano-
ma. Clinical studies of soft tissue sarcoma (Brizel et al, 1996) and
cervical carcinoma (Ho ¨ckel et al, 1996; Rofstad et al, 2000) have
also demonstrated associations between incidence of metastases
and poor oxygenation of the primary tumour. From these clinical
studies, it has not been possible to establish whether hypoxia causes
metastasis or whether the most metastatic cell phenotypes develop
the most hypoxic primary tumours. The D-12 primary tumours
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swere initiated from the same culture of monolayer cells, suggesting
a cause–effect relationship between hypoxia and metastasis in
cancer.
D-12 primary tumours showed distinct hypoxic foci and distinct
vascular hot spots in non-necrotic tissue. We propose the following
hypothesis: a hypoxic focus develops into either a necrotic region
or a vascular hot spot in D-12 tumours, depending on whether
the hypoxia-induced up-regulation of angiogenesis stimulatory
factors in the hypoxic focus is sufﬁciently high to stimulate
adequate neovascularization. Our hypothesis is supported by
several observations. First, small tumours developed hypoxic foci
before they developed vascular hot spots. The delay in the develop-
ment of vascular hot spots relative to the development of hypoxic
foci was 3–4 days. Second, hypoxic foci and vascular hot spots
showed similar size distributions and were scattered throughout
non-necrotic tissue in similar patterns, independent of tumour size.
Third, the density of vascular hot spots was positively correlated to
the density of hypoxic foci in large tumours. The slope of the
regression curve pertaining to tumours with low necrotic fractions
was close to unity and signiﬁcantly higher than that of the regres-
sion curve pertaining to tumours with high necrotic fractions.
Moreover, hypoxia increased the expression and secretion of VEGF
and IL-8 in vitro, and has been shown to stimulate D-12 induced
angiogenesis in vivo (Rofstad and Danielsen, 1999). Treatment with
neutralizing antibody against VEGF, IL-8, or VEGF and IL-8 in
vivo did not change the density of hypoxic foci, but reduced the
density of vascular hot spots and increased the necrotic fraction
comparatively. The anti-VEGF and anti-IL-8 neutralizing antibo-
dies used here have no antiproliferative or cytotoxic effects on
D-12 cells in culture (Rofstad and Halsør, 2000). Most importantly,
examination of immunohistochemical preparations of adjacent
sections revealed a high degree of co-localization of IL-8 and pimo-
nidazole staining in D-12 tumours; the expression of IL-8 was up-
regulated in hypoxic foci and in hypoxic cells adjacent to necroses.
Hypoxia-induced up-regulation of IL-8 has also been demonstrated
by immunohistochemistry in pancreatic cancer xenografts (Shi et
al, 1999) and human ovarian carcinomas (Xu et al, 1999). Up-
regulation of VEGF in hypoxic foci, however, could not be detected
in immunohistochemical preparations of D-12 tumours, perhaps
because VEGF diffused readily from hypoxic tissue into surround-
ing normoxic tissue.
Hypoxia was found to promote spontaneous metastasis in D-12
melanoma; the hypoxic fraction and the density of hypoxic foci
were higher in metastatic than in non-metastatic primary tumours.
The density of hypoxic foci had a higher discriminative power than
the hypoxic fraction, suggesting that the hypoxia-induced metasta-
sis was primarily attributable to hypoxic foci in non-necrotic tissue
rather than to hypoxic regions adjacent to necrosis. There is signif-
icant evidence that the mechanism by which metastasis was
promoted by hypoxic foci involved hypoxia-induced up-regulation
of angiogenesis stimulators and vascular hot spots induced in
hypoxic foci. Thus, the densities of IL-8 positive foci and vascular
hot spots were higher in metastatic than in non-metastatic primary
tumours in untreated mice, and treatment with neutralizing anti-
body against VEGF, IL-8, or VEGF and IL-8 reduced the
incidence of metastases and the density of vascular hot spots
comparatively. Vascular hot spots are composed of immature capil-
laries and capillary sprouts that may facilitate tumour cell
intravasation and hence metastasis by several mechanisms (Fidler
and Ellis, 1994; Weidner, 1995). Immature capillaries are leaky
and have fragmented basement membranes, making them more
accessible to tumour cells than mature capillaries. Capillary sprouts
are characterized by extensive endothelial cell proliferation and
migration, and proliferating and migrating endothelial cells secrete
paracrine growth factors and degradative enzymes that may
advance the escape of tumour cells into the neovasculature. Finally,
growing capillaries may actively promote intravasation by engulﬁng
tumour cells.
The time course experiments suggest that the development of
hypoxic foci and vascular hot spots was a necessary condition for
metastatic dissemination in D-12 melanoma. The tumours started
developing hypoxic foci and vascular hot spots when reaching
wet weights of approximately 10 and 25 mg, respectively, whereas
metastatic dissemination did not occur until a wet weight of
50–60 mg was reached, i.e. until a substantial number of hypoxic
foci and vascular hot spots had developed. The presence of hypoxic
foci and vascular hot spots, however, was not a sufﬁcient condition
for metastasis in D-12 melanoma. Although the densities of
hypoxic foci and vascular hot spots differed signiﬁcantly between
metastatic and non-metastatic primary tumours, a substantial
percentage of the non-metastatic tumours showed density values
within the same ranges as those of the metastatic tumours. Conse-
quently, metastatic disease can probably not be predicted from the
densities of hypoxic foci and vascular hot spots in the primary
tumour.
There is experimental evidence that the mechanism of the
hypoxia-induced spontaneous metastasis in D-12 melanoma also
involved increased probability of tumour cells trapped in the lung
capillary bed to give rise to macroscopic growth, owing to hypoxia-
induced VEGF up-regulation. It has been shown that D-12 cells
exposed to hypoxia in vitro before being inoculated intravenously
in mice have an increased lung colonization efﬁciency relative to
aerobic control cells and that the increase can be prevented by
treatment with anti-VEGF antibody (Rofstad and Danielsen,
1999). Hypoxia-induced VEGF up-regulation may promote the
development of metastases from tumour cells trapped in a second-
ary organ by increasing the permeability of the capillary bed and
hence facilitate tumour cell extravasation, enhancing the survival,
migration and proliferation of extravasated tumour cells, and
stimulating the initial phases of tumour angiogenesis in the
secondary organ (Ferrara and Davis-Smyth, 1997; Rofstad and
Danielsen, 1999; Li et al, 2000).
Some clinical studies have demonstrated associations between
metastasis and hot spot microvessel density in the primary tumour
(Weidner, 1995), whereas others have demonstrated associations
between metastasis and tumour hypoxia (Brizel et al, 1996; Ho ¨ckel
et al, 1996; Rofstad et al, 2000). These two groups of studies have
been considered to be incompatible, mainly because tumour
hypoxia has been shown to be associated with poor tumour vascu-
larization (Vaupel et al, 1989). Our study suggests a mechanism of
hypoxia-induced metastasis that involves induction of vascular hot
spots and thus uniﬁes these clinical observations; tumour hypoxia
leads to elevated secretion of hypoxia-inducible angiogenesis stimu-
lators, elevated secretion of angiogenesis stimulators causes
development of vascular hot spots, vascular hot spots promote
tumour cell intravasation, and increased intravasation results in
increased probability of metastasis. This mechanism does not
necessarily involve VEGF or IL-8; other angiogenesis stimulators
have also been shown to be up-regulated by hypoxia (Grifﬁths et
al, 1997; Hartmann et al, 1999).
Two types of tumour hypoxia have been recognized: chronic or
diffusion-limited hypoxia, arising from limitations in oxygen diffu-
sion owing to oxygen consumption by the tumour cells, and acute
or perfusion-limited hypoxia, resulting from transient cessations in
microregional tumour blood ﬂow (Horsman, 1995). Our study
introduces a need for dividing the diffusion-limited hypoxia into
two subcategories: permanent diffusion-limited hypoxia, i.e. diffu-
sion-limited hypoxia resulting in cell death and development of
necrotic regions, and transient diffusion-limited hypoxia, i.e. diffu-
sion-limited hypoxia leading to angiogenesis and cell
reoxygenation. Tumour oxygenation status was measured polaro-
graphically with needle electrodes in the clinical studies showing
associations between metastasis and tumour hypoxia, and it was
assumed that hypoxia-induced metastases arose from cells in
tumour regions having been subjected to perfusion-limited hypox-
ia, mainly because such cells can be found adjacent to microvessels
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1996; Rofstad et al, 2000). However, perfusion-limited hypoxia is
generally of short duration and may not necessarily induce signiﬁ-
cant gene up-regulation (Horsman, 1995). Our study on the other
hand, suggests that hypoxia-induced metastases arise from cells in
tumour region having been subjected to transient diffusion-limited
hypoxia. Such cells can readily escape into the microvasculature as
described above, and transient diffusion-limited hypoxia most
likely lasts sufﬁciently long for maximum hypoxia-induced gene
up-regulation to occur (Rofstad, 2000).
It should also be noted that the results of our study are not
identical to those of the clinical studies having demonstrated asso-
ciations between metastasis and hot spot microvessel density in the
primary tumour (Weidner, 1995). We found an association
between metastasis and density of vascular hot spots, but no asso-
ciation between metastasis and hot spot microvessel density as was
found in the clinical studies. In fact, the mean hot spot microvessel
density did not differ signiﬁcantly among individual D-12 tumours,
perhaps because they were derived from the same cell line and
thus, in contrast to the clinical tumours, had the same genetic
background. The density of vascular hot spots has not been deter-
mined in clinical specimens, but it is likely to be governed by
mechanisms similar to those governing the hot spot microvascular
density and may thus be correlated to this parameter.
The mechanism of hypoxia-induced metastasis reported here for
D-12 melanoma is by no means the only mechanism by which
tumour hypoxia may induce metastasis. A recent review, based
on novel insights from studies of experimental tumours and cells
in culture and recent advances in gene regulation and signal trans-
duction, has identiﬁed several possible mechanisms of hypoxia-
induced cancer metastasis (Rofstad, 2000). Thus, hypoxia may
induce point mutations and DNA strand breakage leading to dele-
tions, ampliﬁcations and genomic instability. Hypoxia may also
provide a physiological pressure in tumours selecting for metastatic
cell phenotypes. Moreover, hypoxia may induce a temporary
increase in the expression of gene products involved in the meta-
static cascade, either through gene ampliﬁcations or through
normal physiological processes by activating oxygen sensors,
hypoxia signal transduction pathways and DNA transcription
factors (Rofstad, 2000).
In summary, tumour hypoxia induced spontaneous pulmonary
metastasis in D-12 melanoma by a mechanism which involved
induction of vascular hot spots by hypoxic foci, owing to hypox-
ia-induced up-regulation of IL-8 and possibly also of VEGF.
Treatment with anti-VEGF and/or anti-IL-8 neutralizing antibody
led to the development of necrosis rather than vascular hot spots
and inhibited hypoxia-induced metastasis. Our study suggests a
cause–effect relationship between hypoxia and metastasis in cancer
and a poor prognosis of patients having primary tumours charac-
terized by low oxygen tension.
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